首页> 外文期刊>CNS & neurological disorders drug targets >Jingshu Keli and its Components Notoginsenoside R1 and Ginsenoside Rb1 Alleviate the Symptoms of Cervical Myelopathy through Kir3.1 Mediated Mechanisms
【24h】

Jingshu Keli and its Components Notoginsenoside R1 and Ginsenoside Rb1 Alleviate the Symptoms of Cervical Myelopathy through Kir3.1 Mediated Mechanisms

机译:Jingshu Keli及其组分Notoginsenoside R1和人参皂苷RB1通过Kir3.1介导机制来缓解宫颈肌钙病的症状

获取原文
获取原文并翻译 | 示例
           

摘要

Background & Objective: Cervical Spondylotic Myelopathy (CSM) is one of the most serious spinal cord disorders in adults. Pharmacological modulation of ion channels is a common strategy to interfere with CSM and prevent neuronal damage.
机译:背景和目的:颈椎性脊椎病(CSM)是成人中最严重的脊髓障碍之一。 离子通道的药理学调制是干扰CSM并防止神经元损伤的常见策略。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号